Status:
COMPLETED
Effect of Casodex on Tumour Hypoxia - Prostate Cancer
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Canadian Cancer Trials Group
Princess Margaret Hospital, Canada
Conditions:
Prostatic Neoplasms
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Prostate cancers, in common with many other tumours, are often hypoxic; that is, they have low levels of oxygen. It is thought that tumour hypoxia may hasten the progression of cancers and make them m...
Eligibility Criteria
Inclusion
- Men with histologically proven prostatic carcinoma, stage cT2, N0, M0, receiving neoadjuvant bicalutamide plus conformal radiotherapy in study 9907, who have previously participated in the prostate cancer hypoxia project
- informed consent
Exclusion
- Coagulopathy
Key Trial Info
Start Date :
April 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 10 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00188708
Start Date
April 1 2001
End Date
March 10 2022
Last Update
March 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9